Canaccord Genuity Group Reaffirms “Buy” Rating for Core Scientific (NASDAQ:CORZ)

Core Scientific (NASDAQ:CORZ)‘s stock had its “buy” rating reiterated by research analysts at Canaccord Genuity Group in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $36.00 price objective on the stock. Canaccord Genuity Group’s price objective indicates a potential upside of 166.59% from the company’s previous close.

CORZ has been the topic of several other research reports. Keefe, Bruyette & Woods raised Core Scientific from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $25.00 to $28.00 in a report on Thursday, July 30th. Capital One Financial set a $33.00 target price on Core Scientific in a report on Thursday, July 30th. Compass Point reissued a “buy” rating and set a $36.00 target price on shares of Core Scientific in a report on Wednesday, July 29th. Wells Fargo & Company started coverage on Core Scientific in a report on Thursday, September 17th. They set an “overweight” rating and a $28.00 target price on the stock. Finally, Wolfe Research reissued a “buy” rating on shares of Core Scientific in a report on Wednesday, July 29th. Two analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $31.36.

Core Scientific Trading Down 0.0%

NASDAQ:CORZ traded down $0.01 during midday trading on Thursday, hitting $13.50. 9,694,314 shares of the stock were exchanged, compared to its average volume of 12,563,023. Core Scientific has a one year low of $12.31 and a one year high of $30.46. The company has a market capitalization of $4.34 billion, a price-to-earnings ratio of -3.11 and a beta of 5.49. The business has a 50-day moving average price of $17.58 and a two-hundred day moving average price of $21.05.

Core Scientific (NASDAQ:CORZ) last announced its earnings results on Tuesday, July 28th. The company reported ($3.32) EPS for the quarter, missing the consensus estimate of ($0.06) by ($3.26). The company had revenue of $164.20 million during the quarter, compared to analysts’ expectations of $144.83 million. Sell-side analysts forecast that Core Scientific will post -1.36 EPS for the current fiscal year.

Insider Transactions at Core Scientific

In other Core Scientific news, insider Todd DuChene sold 10,000 shares of Core Scientific stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $19.97, for a total value of $199,700.00. Following the transaction, the insider owned 1,969,101 shares in the company, valued at approximately $39,322,946.97. The trade was a 0.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In the last quarter, insiders have purchased 19,000 shares of company stock valued at $342,290 and have sold 100,000 shares valued at $1,881,300. Company insiders own 1.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new position in Core Scientific in the second quarter worth approximately $719,649,000. Jericho Capital Asset Management L.P. grew its position in Core Scientific by 11.4% in the fourth quarter. Jericho Capital Asset Management L.P. now owns 13,038,619 shares of the company’s stock worth $189,842,000 after buying an additional 1,338,796 shares during the last quarter. Bank of America Corp DE grew its position in Core Scientific by 412.5% in the first quarter. Bank of America Corp DE now owns 4,806,363 shares of the company’s stock worth $71,903,000 after buying an additional 3,868,535 shares during the last quarter. Clearline Capital LP grew its position in Core Scientific by 274.2% in the fourth quarter. Clearline Capital LP now owns 4,689,443 shares of the company’s stock worth $68,278,000 after buying an additional 3,436,127 shares during the last quarter. Finally, Apollo Management Holdings L.P. acquired a new position in Core Scientific in the second quarter worth approximately $115,671,000.

Core Scientific News Summary

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Analysts continue to see substantial upside. Canaccord Genuity reaffirmed a “buy” rating with a $36 price target, while BTIG Research maintained its “buy” rating and set a $38 target. Cantor Fitzgerald also reiterated an “overweight” rating with a $39 target. These targets imply significant appreciation from recent trading levels and may support investor confidence. Canaccord Genuity Core Scientific rating
• Positive Sentiment: Core Scientific’s data-center and AI infrastructure strategy remains a key catalyst. The company’s high-density colocation business could benefit from demand for AI and high-performance computing capacity, helping explain why analysts maintain bullish targets despite recent volatility.
• Neutral Sentiment: Third-quarter results are scheduled for November 5, 2026. Management will release results before the market opens and host a conference call at 8:30 a.m. Eastern Time. Investors will likely focus on colocation growth, customer concentration, capital spending, and the outlook for AI infrastructure. Core Scientific earnings announcement
• Negative Sentiment: Insider selling adds a modest negative signal. Director Todd DuChene sold 10,000 shares for approximately $151,200, reducing his holdings by 0.85%. Although he still owns more than 1.15 million shares, the transaction may weigh on sentiment. Core Scientific insider sale
• Negative Sentiment: Tenant-related credit risk remains an overhang. Needham maintained its $35 target even as CoreWeave, a key tenant, faces credit pressure. Any deterioration in CoreWeave’s financial condition could raise concerns about customer concentration, contract execution, or payment risk. Needham Core Scientific target

About Core Scientific

Core Scientific, Inc is a digital infrastructure company that develops and operates data centers in the United States. Its business has historically centered on cryptocurrency mining, particularly the processing of transactions on the Bitcoin network, while also providing hosting and infrastructure services to other mining and technology customers.

The company is expanding its data center capabilities to support high-performance computing and artificial intelligence workloads. Its services include data center operations, power and equipment management, hosting, and related infrastructure support for customers that require substantial computing capacity.

Core Scientific was founded in 2017 and became a publicly traded company through a business combination in 2022.